Form 4 for IRON Disc Medicine, Inc.
Accepted 2023-12-07 00:00:00 ET · period of report 2023-12-05 · accession 0000950170-23-068812 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2023-12-07 | 2023-12-05 | IRON | Bryce Joanne | CFO | M - OptEx | $1.01 | +1,281 | 4,286 | +43% | +$1,294 |
| DMT | 2023-12-07 | 2023-12-05 | IRON | Bryce Joanne | CFO | S - Sale+OE | $56.00 | -2,541 | 2,500 | -50% | -$142.3K |
| DMT | 2023-12-07 | 2023-12-05 | IRON | Bryce Joanne | CFO | M - OptEx | $0.00 | -1,281 | 752 | -63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-05 | M | A | 755 | $1.01 | 5,041 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-05 | M | A | 526 | $1.01 | 4,286 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-05 | S | D | 1,293 | $56.55 | 2,600 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.05 to $57.04, inclusive. |
| 4 | Common | Common Stock | 2023-12-05 | S | D | 1,148 | $55.29 | 3,893 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.93 to $55.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. |
| 5 | Common | Common Stock | 2023-12-05 | S | D | 100 | $57.06 | 2,500 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-12-05 | M | D | 526 | $0.00 | 0 | D | $1.01 · — to 2029-11-05 | 526 Common Stock | (F4) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-12-05 | M | D | 755 | $0.00 | 752 | D | $1.01 · — to 2029-11-05 | 755 Common Stock | (F5) The shares underlying this option vest in 16 equal quarterly installments following May 1, 2020, subject to the Reporting Person's continued service on each such vesting date. |